Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have persistent atrial fibrillation (an irregular heart rhythm that does not stop on its own) along with heart failure symptoms that have not improved enough with medication, and who have been assessed as suitable for a heart procedure called AF ablation, with no more than one previous procedure to isolate the pulmonary veins in the heart.
- People who have been admitted to hospital, or visited an emergency room or heart failure clinic at least once in the past 2 years because of heart failure, and who had a specific blood marker (NT-pro-BNP above 1000 pg/ml or BNP above 250 pg/ml) measured at some point during that period.
- People who have previously taken, or are currently taking, medication to control their heart rate or heart rhythm.
- People who are older than 60 years of age.
Who may not be able to join:
- People with very severe heart failure symptoms (classified as NYHA Class IV) and a very low blood pressure (at or below 80 mmHg) even after receiving the best available treatment.
- People whose life expectancy is less than 2 years.
- People who need a major surgical procedure.
- People who have had a heart attack, stroke, or a heart procedure called PCI within the past 3 months.
- People who already have, or are planned to receive, a device that helps the heart beat in a coordinated way (called a CRT device) or a pacemaker. A device used only to prevent dangerous heart rhythms (an ICD), without a need for pacing, is acceptable.
- People who are currently participating in another controlled clinical trial.
- People who are not able to sign an informed consent form.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +41794616217
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Superiority endpoint; Non-inferiority endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.